Avanir Pharmaceuticals Inc (AVNR.O)


AVNR.O on Nasdaq

4.50USD
14 Jun 2013
Price Change (% chg)

$0.24 (+5.63%)
Prev Close
$4.26
Open
$4.45
Day's High
$4.53
Day's Low
$4.41
Volume
3,678,997
Avg. Vol
1,627,763
52-wk High
$4.78
52-wk Low
$2.07

AVNR.O

Chart for AVNR.O

About

AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its... (more)

Overall

Beta: 1.94
Market Cap (Mil.): $669.68
Shares Outstanding (Mil.): 145.11
Dividend: --
Yield (%): --

Financials

  AVNR.O Industry Sector
P/E (TTM): -- 40.13 30.65
EPS (TTM): -0.40 -- --
ROI: -94.51 2.36 18.83
ROE: -121.06 3.58 19.74
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF67.15 0.00
Pfizer Inc. (PFE.N) $29.10 -0.30
Johnson & Johnson (JNJ.N) $84.86 -1.50
Merck & Co., Inc. (MRK.N) $47.58 -0.17
Bayer AG (BAYGn.DE) €84.19 +0.37
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - AVANIR PHARMACEUTICALS,INCORPORATION (AVNR-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
AVANIR Pharmaceuticals
Provider: S&P Capital IQ Quantitative Report
$69.00
Buy
AVANIR PHARMACEUTICALS INC (AVNR) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Avanir Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AVANIR PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks